Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Stefan G C, Mestrum"'
Autor:
Stefan G. C. Mestrum, Norbert C. J. de Wit, Eline M. P. Cremers, Roosmarie J. M. Drent, Frans C. S. Ramaekers, Anton H. N. Hopman, Math P. G. Leers
Publikováno v:
HemaSphere, Vol 6, Iss 12, p e804 (2022)
Externí odkaz:
https://doaj.org/article/b9e57974a5ba4b56be736fd375b52052
Autor:
Stefan G. C. Mestrum, Roanalis B. Y. Vanblarcum, Roosmarie J. M. Drent, Bert T. Boonen, Wouter L. W. van Hemert, Frans C. S. Ramaekers, Anton H. N. Hopman, Math P. G. Leers
Publikováno v:
Cytometry Part A, 101(7), 552-563. Wiley
Recent developments in clinical flow cytometry allow the simultaneous assessment of proliferative and anti-apoptotic activity in the different hematopoietic cell lineages and during their maturation process. This can further advance the flow cytometr
Publikováno v:
International journal of molecular sciences. 23(18)
Acute myeloid leukemia (AML) is a myeloid malignancy that is characterized by the accumulation of leukemic blast cells, which originate from hematopoietic stem cells that have undergone leukemic transformation and/or are more mature progenitors that
Publikováno v:
Blood Adv
Standardization of the detection and quantification of leukocyte differentiation markers by the EuroFlow Consortium has led to a major step forward in the integration of flow cytometry into classification of leukemia and lymphoma. In our opinion, thi
Autor:
Roosmarie J. M. Drent, Stefan G. C. Mestrum, Norbert C. J. de Wit, Math P. G. Leers, Anton H. N. Hopman, Frans C. S. Ramaekers
Publikováno v:
Cytometry Part B: Clinical Cytometry. 100:322-330
The proliferation marker Ki-67 is widely used within the field of diagnostic histopathology as a prognostic marker for solid cancers. However, Ki-67 is hardly used for prognostic and diagnostic purposes in flow cytometric analyses of hematologic neop
Autor:
Stefan G C, Mestrum, Norbert C J, de Wit, Roosmarie J M, Drent, Anton H N, Hopman, Frans C S, Ramaekers, Math P G, Leers
Publikováno v:
Cytometry. Part B, Clinical Cytometry
The proliferation marker Ki‐67 is widely used within the field of diagnostic histopathology as a prognostic marker for solid cancers. However, Ki‐67 is hardly used for prognostic and diagnostic purposes in flow cytometric analyses of hematologic
Autor:
Roanalis B.Y. Vanblarcum, Norbert C. J. de Wit, Roosmarie J. M. Drent, Mathie P.G. Leers, Frans C. S. Ramaekers, Stefan G. C. Mestrum, Bert Boonen, Wouter L. W. van Hemert, Anton H. N. Hopman
Publikováno v:
Blood. 138:3444-3444
Introduction: Standardization of the detection and quantification of leukocyte differentiation markers by the EuroFlow Consortium has led to a major step forward in the integration of flow cytometry in classification of myelodysplastic syndromes (MDS